Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 BioPhase 2 basket trial planned to evaluate ...
In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...
A recent study concluded that hemorrhagic myocardial infarction (hMI) remains a common and clinically significant ...
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...
A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...
Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...
Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...
Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...
Around half of study participants, all age 65 or younger, wouldn’t have been eligible for statins if they’d sought care 2 days earlier.
Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...
Actor Kang Nam-gil reported his health.Kang Nam-gil appeared on TV CHOSUN 'Perfect Life', which aired on the 19th, to reveal ...
The annual meeting of the American Heart Association was held this year from Nov. 7 to 10 in New Orleans, drawing attendees ...